Suppr超能文献

人激肽原结构域3的克隆、表达及特性分析

Cloning, expression and characterization of human kininogen domain 3.

作者信息

Auerswald E A, Rössler D, Mentele R, Assfalg-Machleidt I

机构信息

Abteilung für Klinische Chemie und Klinische Biochemie, Ludwig Maximilians Universität München, Germany.

出版信息

FEBS Lett. 1993 Apr 19;321(1):93-7. doi: 10.1016/0014-5793(93)80628-8.

Abstract

The internal domain 3 of the heavy chain of human kininogen, a cysteine proteinase inhibitor, was amplified by a polymerase chain reaction from the kininogen cDNA clone phKG36. The DNA fragment was expressed in Escherichia coli using the ompA expression vector pASK40 and the resulting protein was isolated from periplasm, purified by S-carboxymethylpapain affinity- and ion-exchange chromatography. The recombinant human kininogen domain 3 is 92% pure, reacts with anti-kininogen antibodies and is actively inhibitory. The expected amino acid sequence of ANSM-[G253-S377] kininogen was confirmed; the inhibitor has a molecular mass of 14,396 Da and an isoelectric point of 6.0 (pH). The determined Ki values of the complexes with papain and cathepsin L are similar to those measured previously with proteolytically liberated kininogen domain 3, and those of single-domain cystatins, like chicken egg white cystatin. However, recombinant kininogen domain 3 is a weak inhibitor of cathepsin B (Ki = 63 nM) as it has been found for native L-kininogen (Ki = 340 nM).

摘要

人激肽原重链的内部结构域3是一种半胱氨酸蛋白酶抑制剂,通过聚合酶链反应从激肽原cDNA克隆phKG36中扩增得到。该DNA片段利用ompA表达载体pASK40在大肠杆菌中表达,所产生的蛋白质从周质中分离出来,通过S-羧甲基木瓜蛋白酶亲和层析和离子交换层析进行纯化。重组人激肽原结构域3的纯度为92%,能与抗激肽原抗体发生反应,且具有活性抑制作用。证实了ANSM-[G253-S377]激肽原的预期氨基酸序列;该抑制剂的分子量为14396 Da,等电点为6.0(pH)。与木瓜蛋白酶和组织蛋白酶L形成的复合物的测定Ki值与先前用蛋白水解释放的激肽原结构域3以及单结构域半胱氨酸蛋白酶抑制剂(如鸡卵清半胱氨酸蛋白酶抑制剂)测得的值相似。然而,重组激肽原结构域3是组织蛋白酶B的弱抑制剂(Ki = 63 nM),这与天然L-激肽原(Ki = 340 nM)的情况相同。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验